Copyright
©The Author(s) 2021.
World J Hepatol. Feb 27, 2021; 13(2): 218-232
Published online Feb 27, 2021. doi: 10.4254/wjh.v13.i2.218
Published online Feb 27, 2021. doi: 10.4254/wjh.v13.i2.218
Figure 3 Matrix metalloproteinase productions according to fibrosis stage.
Serum concentrations of A: Matrix metalloproteinase (MMP)-2; B: MMP-7 and C: MMP-9 of chronic hepatitis C patients classified according to fibrosis grades F0, F1, F2, F3 and F4. Statistical differences of MMP-7 were observed in 1 = F0 vs F1a; 2 = F0 vs F3b; 3 = F0 vs F4b; 4 = F1 vs F3b; 5 = F1 vs F4b; 6 = F2 vs F3a, 7 = F3 vs F4b. Data are expressed as mean ± standard error of the mean. aP < 0.05; bP < 0.01.
- Citation: Martinez-Castillo M, Hernandez-Barragan A, Flores-Vasconcelos I, Galicia-Moreno M, Rosique-Oramas D, Perez-Hernandez JL, Higuera-De la Tijera F, Montalvo-Jave EE, Torre-Delgadillo A, Cordero-Perez P, Muñoz-Espinosa L, Kershenobich D, Gutierrez-Reyes G. Production and activity of matrix metalloproteinases during liver fibrosis progression of chronic hepatitis C patients. World J Hepatol 2021; 13(2): 218-232
- URL: https://www.wjgnet.com/1948-5182/full/v13/i2/218.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i2.218